Jitsubo Overview

Founded 2005
Status Acquired/​Merged
Latest Deal Type Later Stage VC
Investors 3

Jitsubo General Information


Developer of peptide generic products intended to contribute to the well-being of society through innovative peptide therapeutics. The company offers services related to peptide pharmaceuticals, contract manufacturing of peptide APIs and licensing regarding active ingredient manufacturing technology for peptides, enabling the patient to get peptide pharmaceuticals at a low and affordable cost.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • 1-1-43, Suehiro-cho, Tsurumi
  • Yokohama
  • Kanagawa, 230-0045
  • Japan
+81 000-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Jitsubo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 11-Nov-2016 Completed Generating Revenue
1. Merger/Acquisition 26-Dec-2014 00.000 00.000 Completed Generating Revenue

Jitsubo Executive Team (6)

Name Title Board Seat Contact Info
Kazuaki Kanai Ph.D Chief Executive Officer, Chief Technology Officer & Representative Director
Kazuhiro Chiba Ph.D Co-Founder
Kiichiro Ohya Vice President & Board Member

3 Former Executives

Jitsubo Board Members (4)

Name Representing Role Since
Kazunobu Nishimura Jitsubo Board Member 000 0000
Kiichiro Ohya Jitsubo Vice President & Board Member 000 0000
Tadayoshi Yasui Self Board Member 000 0000
Tsuyoshi Dai Self Board Member 000 0000

Ready to get started?

Request a free trial